type here...

CATEGORIES

Medication

LATEST

1234Page 3 of 4

TRENDING

EDITORS CHOICE

How Dare You Criticize Psychiatrists Who Praise Studies of Psychedelics As Antidepressants?

James Coyne -
All claims about treatments affecting human health and well-being should be subject to robust review. That review requires someone to facilitate criticism, locate qualified critics, and bring them into the discussion.

AI Presents Dangers That Hide With Incredible Ease

Pat Farrell PhD -
Artificial intelligence, aka AI, has become so advanced that it might be difficult to know whether you are speaking to a live person or...

The Trauma of Witnessing Charlie Kirk’s Murder and PTSD

Pat Farrell PhD -
The psychological effects of public space shootings extend beyond physical harm because they create a broad psychological impact on everyone present at the scene....

Achieve Life Sciences Announces Statistically Significant Smoking Cessation Results in Phase 3 ORCA-2 Clinical Trial of Cytisinicline in Adult Smokers

Medika Life -
Clinical results in primary and secondary endpoints for 6- and 12-week experimental smoking cessation treatment reported by company sponsor.

CONNECT WITH US ON SOCIAL MEDIA

Medika Life is a unique, not-for-profit operating unit of FINN Partners and maintains an independent voice. Authors opinions may not necessarily represent those shared by FINN Partners and content cannot be promotional - rather informational centered on health issues, life science innovation, ecohealth and patient experience.

© Medika Life 2020 - 2022

Compliance

CORPORATE & MEDIA

Popular categories